Bismuth subcitrate potassium, metronidazole, and tetracycline and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Bismuth subcitrate potassium, metronidazole, and tetracycline and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bismuth subcitrate potassium / metronidazole / tetracycline
Brand name: Pylera
Synonyms: Bismuth Subcitrate, Metronidazole, and Tetracycline
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Moxifloxacin
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Moxifloxacin (Systemic)
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Moxifloxacin Hydrochloride
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Moxifloxacin Injection
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Moxifloxacin Intravenous
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Bismuth Subcitrate, Metronidazole, and Tetracycline
- Moxetumomab pasudotox-tdfk Intravenous-Bismuth Subgallate
- Moxetumomab pasudotox-tdfk Intravenous-Bismuth subsalicylate
- Moxetumomab pasudotox-tdfk Intravenous-Bismuth Subsalicylate Chewable Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Bismuth Subsalicylate Suspension
- Moxetumomab pasudotox-tdfk Intravenous-Bismuth Subsalicylate Tablets